Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Bristol-Myers Squibb

Clinicaltrial registered16 Nov 2026

Bristol-Myers Squibb

16 Nov 2026: Trial registered · A Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
16 Nov 2026
Title
A Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Conditions
Advanced Solid Malignancies
Phase
Phase 1, Phase 2
Study Type
Interventional
Status
Not Yet Recruiting
Countries
United States, Canada
Country
United States
Reference
NCT07939815
Location
United States, Canada
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Bristol-Myers Squibb

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Bristol-Myers Squibb in our registers.

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.